OssDsign® Spine Registry Study ("Propel")
Part of paid clinical trials in Fresno, California.
- Sponsor
- OssDsign
- Study ID
- NCT05329129
- Status
- Recruiting
Conditions
- Degenerative Disc Disease
- Spinal Stenosis
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- OssDsign® Catalyst — DEVICEAn osteoconductive, resorbable, porous, 100 % nano synthetic calcium phosphate bone void filler
Study Details
The purpose of this multi-center, prospective, observational registry is to gather information on the clinical outcomes and real-world use of commercially available bone graft substitutes manufactured by OssDsign® AB, in patients who require spine fusion.
Key Dates
- Start date
- Mar 23, 2022
- Status verified
- Jun 2026
- Primary completion
- Mar 23, 2030
- Completion
- Apr 1, 2030
Study Design
- Enrollment
- 450 participants (estimated)
Primary Outcome Measure
Rate of bone fusion [ Time Frame: 12 months ± 60 days post-operative examination ]
Central Contacts
- jeff Feldhaus13476694903
- Pete weiman13479540542
Locations (15)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Community Health Partners Neuroscience | Fresno | California | 93720 | Lizbeth Gasga-Rodriquez, CRC Derek Taggard, MD (PRINCIPAL_INVESTIGATOR) |
| Memorial Orthopaedic Surgical Group | Long Beach | California | 90806 | Philip S Yuan, MD (PRINCIPAL_INVESTIGATOR) |
| San Diego Neurosurgery | San Diego | California | 92024 | - |
| Orthopedic Associates of Hartford | Hartford | Connecticut | 06102 | - |
| Central Connecticut Neurosurgery and Spine | New Britian | Connecticut | 06051 | Ahmed Khan, MD (PRINCIPAL_INVESTIGATOR) |
| Yale Center for Clinical Investigation, Yale School of Medicine | New Haven | Connecticut | 06519 | Manuel Avedissian, MD, MS Peter Whang, MD (PRINCIPAL_INVESTIGATOR) |
| Minimally Invasive Spine Center of South Florida | Miami | Florida | 33133 | Nicole Graveran Jonathan Gottlieb, MD (PRINCIPAL_INVESTIGATOR) |
| Foundation for Orthopaedic Research and Education | Tampa | Florida | 33607 | Brooks Osburn, MD (PRINCIPAL_INVESTIGATOR) |
| Northeast Georgia Medical Center | Gainesville | Georgia | 30501 | - |
| Carle Foundation Hospital, NeuroScience Institute | Urbana | Illinois | 61801 | - |
| Orthopaedic Institute of Western Kentucky | Paducah | Kentucky | 42001 | - |
| OrthoBethesda Research Foundation | Bethesda | Maryland | 20817 | - |
| Twin Cities Orthopedics | Edina | Minnesota | 55435 | - |
| University Orthopedics Center | State College | Pennsylvania | 16801 | James Burke, M.D., PhD., FAANS (PRINCIPAL_INVESTIGATOR) |
| Texas Spine Consultants | Addison | Texas | 75001 | Haariss S Ilyas, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Fresno, CA
By research site
Community Health Partners Neuroscience· Fresno, CAMemorial Orthopaedic Surgical Group· Long Beach, CASan Diego Neurosurgery· San Diego, CAOrthopedic Associates of Hartford· Hartford, CTCentral Connecticut Neurosurgery and Spine· New Britian, CTYale Center for Clinical Investigation, Yale School of Medicine· New Haven, CT
Related Studies
- Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal ConditionsNot Yet Recruiting · R3 Stem Cell · Encino, California
- Advanced Materials Science in XLIF StudyEnrolling By Invitation · NuVasive · Hartford, Connecticut
- The Course of Hip Flexion Weakness Following LLIF or ALIFEnrolling By Invitation · Rush University Medical Center · Chicago, Illinois
- ACDF Using Structural Allograft vs. Tritanium CRecruiting · Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Pittsburgh, Pennsylvania